NASDAQ:EIKN
The current stock price of EIKN is 14.88 USD.
ChartMill assigns a technical rating of 3 / 10 to EIKN.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.13 | 410.174B | ||
| AMGN | AMGEN INC | 17.12 | 209.016B | ||
| GILD | GILEAD SCIENCES INC | 16.82 | 184.799B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.84 | 126.056B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.02 | 82.638B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.53 | 43.982B | ||
| INSM | INSMED INC | N/A | 31.848B | ||
| NTRA | NATERA INC | N/A | 28.947B | ||
| BIIB | BIOGEN INC | 12.36 | 28.152B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.44 | 21.698B |
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
EIKON THERAPEUTICS INC
230 Harriet Tubman Way
Hayward CALIFORNIA US
Employees: 0
Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
The current stock price of EIKN is 14.88 USD. The price increased by 7.98% in the last trading session.
EIKN does not pay a dividend.
EIKN has a ChartMill Technical rating of 3 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
EIKON THERAPEUTICS INC (EIKN) operates in the Health Care sector and the Biotechnology industry.